Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Adma Biologics (ADMA) over the last 6 years, with Sep 2025 value amounting to $245.5 million.

  • Adma Biologics' Shares Outstanding (Diluted Average) rose 0.28% to $245.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.5 million, marking a year-over-year increase of 0.28%. This contributed to the annual value of $243.3 million for FY2024, which is 8.65% up from last year.
  • Adma Biologics' Shares Outstanding (Diluted Average) amounted to $245.5 million in Q3 2025, which was down 1.25% from $248.6 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Shares Outstanding (Diluted Average) registered a high of $248.6 million during Q2 2025, and its lowest value of $115.7 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $237.1 million, with a median of $242.2 million in 2024.
  • Data for Adma Biologics' Shares Outstanding (Diluted Average) shows a peak YoY soared of 69.35% (in 2022) over the last 5 years.
  • Over the past 5 years, Adma Biologics' Shares Outstanding (Diluted Average) (Quarterly) stood at $139.6 million in 2021, then spiked by 41.77% to $197.9 million in 2022, then rose by 13.19% to $224.0 million in 2023, then rose by 8.65% to $243.3 million in 2024, then climbed by 0.28% to $245.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $245.5 million for Q3 2025, versus $248.6 million for Q2 2025 and $244.7 million for Q1 2025.